Supporting veterans with innovative healthcare
We understand that veterans deserve the best healthcare possible. Our mission drives us every day to develop innovative treatments, therapies, and products that lead to better outcomes for patients. We’re here to partner with you to bring these solutions to our veterans to ensure they get the care they need.
Endoscopy health solutions
Patient-inspired innovation
The possibility of helping patients live longer, healthier lives energizes our work in new ways every day. Our teams are focused on increasing veteran access to our most innovative technologies by streamlining procurement for government healthcare facilities. See how we're collaborating with partners worldwide to create patient-centered solutions that benefit veterans and government healthcare providers.
Discover Genius Academy.
Find a virtual educational platform with relevant resources on artificial intelligence (AI) in GI care.
Harness the power of AI-assisted colonoscopy with the GI Genius™ intelligent endoscopy module.
The GI Genius™ intelligent endoscopy module is the first-to-market, computer-aided polyp detection system powered by AI. We empower physicians to detect colorectal polyps through enhanced visualization during colonoscopy.
Lung solutions
Giving veterans the fighting chance they deserve
Lung cancer remains the number one cause of cancer deaths in the Unites States.1 And lung cancer rates among veterans are 25% higher than the general population.2
See our lung health and thoracic surgery portfolio.
Let’s find, track, and treat lung cancer together.
At Medtronic, we are dedicated to meaningful innovations to address unmet clinical needs, drive cost effectiveness, along with operational programmatic impact, ultimately reinventing the patient journey — from earlier identification, diagnosis, and enabling surgical treatment.
Perform lung biopsy with greater confidence
Discover the ILLUMISITE™ fluoroscopic navigation platform.
Clinician perspectives on ILLUMISITE™ fluoroscopic navigation platform
Lung health outreach and patient resources
Lung health outreach toolkit
Explore the tools we’ve created to help you get the word out to patients on the importance of early screening, new screening eligibility, and how to schedule a low-dose CT scan for those at high risk for lung cancer.
Ear, nose, and throat medical specialties
Find the latest clinical perspectives, medical education and solutions for ENT physicians, and head and neck surgeons.
Chronic pain treatment
Providing relief for patients suffering from chronic pain.
Spinal cord stimulation (SCS) for pain
Spinal cord stimulation is a proven, non-opioid, FDA-approved way to manage chronic pain. Medtronic SCS pain therapy is now approved to also help treat pain associated with diabetic peripheral neuropathy (DPN). SCS works by disrupting the pain signals traveling between the spinal cord and the brain.
Bryan’s story — Air Force veteran
“When I learned about the stimulators and the fact that I could try it to see if it worked, that was very appealing to me. And I thought, ‘well, I wouldn’t buy a car unless I test drove it,’ so let’s test drive this stimulator, and see how it works."
Discover the SynchroMed™ II pump.
Targeted drug delivery is a safe, proven, and effective way to manage chronic pain with fewer side effects and lower doses than systemic medication.3,4
Learn more about the important safety information for SCS.
Learn more about the important safety information for TDD.
1
Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021;71(1):7-33. Erratum in: CA Cancer J Clin. 2021;71(4):359.
2
Risk of Lung Cancer in the Military. The lung Cancer Center Website. lungcancercenter.com/who-lung-cancer-affects/military/. Accessed September 11, 2023.
3
Smith TJ, Swainey C, Coyne PJ. Pain management, including intrathecal pumps. Curr Pain Headache Rep. 2005 Aug;9(4):243–248
4
Schultz DM, Abd-Elsayed A, Calodney A, Stromberg K, Weaver T, Spencer RJ. Targeted Drug Delivery for Chronic Nonmalignant Pain: longitudinal data from the Product Surveillance Registry. Neuromodulation. 2021;24(7):1167–1175